Evidence map›Paper›PMID 22137262›Full record

ArticleThe Journal of nutritional biochemistry2012

Epigallocatechin gallate induces expression of heme oxygenase-1 in endothelial cells via p38 MAPK and Nrf-2 that suppresses proinflammatory actions of TNF-α.

Philomena Pullikotil, Hui Chen, Ranganath Muniyappa, Cynthia C Greenberg, Shutong Yang, Chad E N Reiter, Ji-Won Lee, Jay H Chung, Michael J Quon

Abstract read
In one paragraph

Article in The Journal of nutritional biochemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 104 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Green tea polyphenol EGCg induces cell fusionBiochemistry and biophysics reports · 2023
    Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Biological Effects of EGCG@MOF Zn(BTC)Molecules (Basel, Switzerland) · 2022
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. The Intrinsic Virtues of EGCG, anMolecules (Basel, Switzerland) · 2020
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Philomena PullikotilDiabetes Unit, National Center for Complementary and Alternative Medicine, Bethesda, MD 20892, USA.
Hui Chen
Ranganath Muniyappa
Cynthia C Greenberg
Shutong Yang
Chad E N Reiter
Ji-Won Lee
Jay H Chung
Michael J Quon
National Center for Complementary and Integrative Health · USNational Heart Lung and Blood Institute · USNational Institutes of Health · US

Funding

Treatment for obesityZIAHL006118 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI CHUNG, JAY H · 2011 to 2019
$11.2M
Effect of Green Tea Polyphenols on Endothelial Function and Blood PressureZIAAT000013 · NCCIH · NATIONAL CENTER FOR COMPLEMENTARY & INTEGRATIVE HEALTH · PI QUON, MICHAEL J. · 2009 to 2010
$1.0M
Intramural NIH HHS ZIA AT000013
6 · The paper itself

Abstract

Epigallocatechin gallate (EGCG), the major polyphenol in green tea, acutely stimulates production of nitric oxide (NO) from vascular endothelium to reduce hypertension and improve endothelial dysfunction in spontaneously hypertensive rats. Herein, we explored additional mechanisms whereby EGCG may mediate beneficial cardiovascular actions. When compared with vehicle-treated controls, EGCG treatment (2.5 μM, 8 h) of human aortic endothelial cells (HAEC) caused a ~three-fold increase in heme oxygenase-1 (HO-1) mRNA and protein with comparable increases in HO-1 activity. This was unaffected by pretreatment of cells with wortmannin, LY294002, PD98059 or L-NAME (PI 3-kinase, MEK and NO synthase inhibitors, respectively). Pretreatment of HAEC with SB203580 (p38 MAPK inhibitor) or siRNA knockdown of p38 MAPK completely blocked EGCG-stimulated induction of HO-1. EGCG treatment also inhibited tumor-necrosis-factor-α-stimulated expression of vascular cell adhesion molecule (VCAM)-1 and decreased adhesion of monocytes to HAEC. siRNA knockdown of HO-1, p38 MAPK or Nrf-2 blocked these inhibitory actions of EGCG. In HAEC transiently transfected with a human HO-1 promoter luciferase reporter (or an isolated Nrf-2 responsive region), luciferase activity increased in response to EGCG. This was inhibitable by SB203580 pretreatment. EGCG-stimulated expression of HO-1 and Nrf-2 was blocked by siRNA knockdown of Nrf-2 or p38 MAPK. Finally, liver from mice chronically treated with EGCG had increased HO-1 and decreased VCAM-1 expression. Thus, in vascular endothelium, EGCG requires p38 MAPK to increase expression of Nrf-2 that drives expression of HO-1, resulting in increased HO-1 activity. Increased HO-1 expression may underlie anti-inflammatory actions of EGCG in vascular endothelium that may help mediate beneficial cardiovascular actions of green tea.

Indexed as

Enzyme InductionMAP Kinase Signaling SystemAnimalsAnti-Inflammatory Agents, Non-SteroidalAntioxidant Response ElementsAortaCatechinCell AdhesionCells, CulturedEndothelium, VascularHeme Oxygenase-1HumansLiverMembrane ProteinsMiceMice, Inbred C57BLAnti-Inflammatory Agents, Non-SteroidalCatechinepigallocatechin gallateHeme Oxygenase-1HMOX1 protein, humanHmox1 protein, mouseMembrane ProteinsNFE2L2 protein, humanNF-E2-Related Factor 2p38 Mitogen-Activated Protein KinasesRNA, MessengerTumor Necrosis Factor-alphaVascular Cell Adhesion Molecule-1

Identifiers

PMID22137262
PMCPMC3296830
OpenAlexW2005581076

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.